162 related articles for article (PubMed ID: 698969)
21. Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients.
Liu ZB; Liu GY; Yang WT; Di GH; Lu JS; Shen KW; Shen ZZ; Shao ZM; Wu J
Oncol Rep; 2008 Oct; 20(4):987-94. PubMed ID: 18813844
[TBL] [Abstract][Full Text] [Related]
22. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
[TBL] [Abstract][Full Text] [Related]
23. Relationship of presence of progesterone receptors to prognosis in early breast cancer.
Pichon MF; Pallud C; Brunet M; Milgrom E
Cancer Res; 1980 Sep; 40(9):3357-60. PubMed ID: 7427948
[TBL] [Abstract][Full Text] [Related]
24. Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells.
Yamashita J; Horiuchi S; Kimura M; Nishimura R; Akagi M
Jpn J Cancer Res; 1986 Feb; 77(2):177-81. PubMed ID: 3082829
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic value of estrogen receptors in breast cancer (author's transl)].
Reiner G; Jakesz R; Kolb R; Bettelheim P; Bieglmayer C; Spona J
Chir Forum Exp Klin Forsch; 1980; ():315-8. PubMed ID: 7389473
[TBL] [Abstract][Full Text] [Related]
26. [Estrogen receptor status and expression of carbohydrate antigens in breast cancer].
Sowa M; Chung YS; Kato Y; Nishimura M; Kubo T; Maekawa H; Fujimoto Y; Umeyama K; Kawahara M
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1296-304. PubMed ID: 2794653
[TBL] [Abstract][Full Text] [Related]
27. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
[TBL] [Abstract][Full Text] [Related]
29. [Steroid receptors--their meaning in the treatment of breast neoplasms].
Aiginger P
Acta Med Austriaca; 1978; 5(4-5):156-8. PubMed ID: 756130
[TBL] [Abstract][Full Text] [Related]
30. Steroid hormone receptors in the management of human breast cancer.
Knight WA; Osborne CK; Yochmowitz MG; McGuire WL
Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982
[TBL] [Abstract][Full Text] [Related]
31. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
32. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
McClelland RA; Finlay P; Walker KJ; Nicholson D; Robertson JF; Blamey RW; Nicholson RI
Cancer Res; 1990 Jun; 50(12):3545-50. PubMed ID: 2187598
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptors, antibodies and hormone dependent cancer.
DeSombre ER; Greene GL; King WJ; Jensen EV
Prog Clin Biol Res; 1984; 142():1-21. PubMed ID: 6538684
[No Abstract] [Full Text] [Related]
34. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
35. [Operable carcinoma of the breast. Prognostic value of estradiol receptors. Preliminary report (author's transl)].
Cheix F; Biron A; Bailly C; Mayer M; Pommatau E; Saez S
Nouv Presse Med; 1980 Mar; 9(13):933-5. PubMed ID: 7360626
[TBL] [Abstract][Full Text] [Related]
36. The estrogen receptor test: a prognostic tool in primary breast cancer.
Logan LA; Cripps MC; Hirte WE; Rapp EF
Can J Surg; 1982 Sep; 25(5):581-4. PubMed ID: 7116258
[TBL] [Abstract][Full Text] [Related]
37. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
[TBL] [Abstract][Full Text] [Related]
38. [Estrogen receptors of the human breast].
El'tsina NV
Vopr Onkol; 1978; 24(8):108-15. PubMed ID: 358579
[No Abstract] [Full Text] [Related]
39. Hormone receptors in breast cancer and response to chemotherapy.
Lippman ME; Allegra JC
N Engl J Med; 1979 May; 300(18):1054. PubMed ID: 431604
[TBL] [Abstract][Full Text] [Related]
40. Estradiol receptor analysis in human breast cancer tissue by isoelectric focusing in polyacrylamide gel.
Gustafsson JA; Gustafsson SA; Nordenskjöld B; Okret S; Silfverswärd C; Wrange O
Cancer Res; 1978 Nov; 38(11 Pt 2):4225-8. PubMed ID: 29706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
